Format

Send to

Choose Destination
Br J Haematol. 2019 May;185(3):410-417. doi: 10.1111/bjh.15735. Epub 2019 Jan 4.

The prevention of glucocorticoid-induced osteoporosis in patients with immune thrombocytopenia receiving steroids: a British Society for Haematology Good Practice Paper.

Author information

1
Department of Haematology, Leeds Teaching Hospitals, Leeds, UK.
2
Royal Manchester Children's Hospital, Manchester University Hospitals NHS Foundation Trust, Manchester Academic Health Science Centre, Manchester, UK.
3
Faculty of Medical & Human Sciences, University of Manchester, Manchester, UK.
4
Department of Haematology, Manchester Royal Infirmary, Manchester, UK.
5
Department of Haematology, Barts& The London School of Medicine & Dentistry, London, UK.
6
Department of Haematology, Kent and Canterbury Hospital, Canterbury, UK.
7
Department of Haematology, Leicester Royal Infirmary, Leicester, UK.
8
University Hospitals Bristol NHS Foundation Trust, Bristol, UK.
9
Department of Cellular and Molecular Medicine, University of Bristol, Bristol, UK.
10
Department of Haematology, Glasgow Royal Infirmary, Glasgow, UK.
11
Centre for Metabolic Bone Diseases, University of Sheffield Medical School, Sheffield, UK.
12
Institute for Health and Ageing, Australian Catholic University, Melbourne, Australia.
13
Department of Medicine, Addenbrooke's Hospital, Cambridge, UK.

KEYWORDS:

ITP ; bisphosphonates; corticosteroids; immune thrombocytopenia; osteoporosis

PMID:
30609018
DOI:
10.1111/bjh.15735

Supplemental Content

Full text links

Icon for Wiley
Loading ...
Support Center